# A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

> **NCT00471237** · PHASE2 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 564 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Ronacaleret
- **DRUG:** Teriparatide
- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT00471237
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05-14
- **Primary completion:** 2008-12-26
- **Final completion:** 2008-12-26
- **Target enrollment:** 564 (ACTUAL)
- **Why stopped:** Terminated for futility by sponsor after a pre-planned interim review of data
- **Last updated:** 2017-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471237, "A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00471237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*